Maternal anticancer drug exposure and leukemia; PIEZO1-TMEM16F coupling in hereditary xerocytosis; NPM1 MRD during venetoclax therapy in NPM1-mutated AML
This episode covers the link between parental occupational exposure to anticancer drugs and childhood cancer, the role of PIEZO1 in hereditary xerocytosis, and the evaluation of measurable residual disease in NPM1-mutated AML patients undergoing venetoclax treatment.